Skip to main content
In stock | Targeted Therapy (Investigational)

Debio 1347 (FGFR Inhibitor)

Oncology Type Solid Tumour
Drug Class / Mechanism FGFR Inhibitor
No Image
Description

Debio 1347 (FGFR Inhibitor) is classified as a FGFR Inhibitor, sourced for use within our Targeted Therapy (Investigational) portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic Category Targeted Therapy (Investigational)
Oncology Type Solid Tumour

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3